Works matching IS 11782595 AND DT 2017 AND VI 31 AND IP 5
Results: 7
Preferences for Receiving Results from a Rare Disease Clinical Trial: A Survey of Subjects with Friedreich's Ataxia and their Parents.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 329, doi. 10.1007/s40290-017-0201-y
- By:
- Publication type:
- Article
First Amendment Protection of Evidence-Based Promotion of Prescription Drugs: A Study of Published Clinical Evidence Supporting Off-Label Promotion in the USA.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 309, doi. 10.1007/s40290-017-0202-x
- By:
- Publication type:
- Article
Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 339, doi. 10.1007/s40290-017-0203-9
- By:
- Publication type:
- Article
Forum.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 353, doi. 10.1007/s40290-017-0204-8
- Publication type:
- Article
Novel Early Phase Clinical Trial Design in Oncology.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 297, doi. 10.1007/s40290-017-0205-7
- By:
- Publication type:
- Article
Major Pharmaceutical Conferences and Courses.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 371, doi. 10.1007/s40290-017-0206-6
- Publication type:
- Article
Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 317, doi. 10.1007/s40290-017-0198-2
- By:
- Publication type:
- Article